nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—Melatonin—CALR—esophageal cancer	0.0299	0.3	CrCbGaD
Agomelatine—Indomethacin—GLO1—esophageal cancer	0.024	0.24	CrCbGaD
Agomelatine—CYP2C9—Capecitabine—esophageal cancer	0.0223	0.665	CbGbCtD
Agomelatine—CYP2C9—Cisplatin—esophageal cancer	0.0112	0.335	CbGbCtD
Agomelatine—Nabumetone—PTGS1—esophageal cancer	0.00968	0.0971	CrCbGaD
Agomelatine—Melatonin—CYP1B1—esophageal cancer	0.00653	0.0655	CrCbGaD
Agomelatine—Nabumetone—PTGS2—esophageal cancer	0.00554	0.0555	CrCbGaD
Agomelatine—Indomethacin—ABCC2—esophageal cancer	0.0048	0.0481	CrCbGaD
Agomelatine—Melatonin—CYP19A1—esophageal cancer	0.00479	0.0481	CrCbGaD
Agomelatine—Infection—Carboplatin—esophageal cancer	0.00476	0.0364	CcSEcCtD
Agomelatine—Naproxen—PTGS1—esophageal cancer	0.00448	0.0449	CrCbGaD
Agomelatine—Rash erythematous—Capecitabine—esophageal cancer	0.0038	0.029	CcSEcCtD
Agomelatine—Indomethacin—PTGS1—esophageal cancer	0.00363	0.0364	CrCbGaD
Agomelatine—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00291	0.0222	CcSEcCtD
Agomelatine—Face oedema—Cisplatin—esophageal cancer	0.00276	0.0211	CcSEcCtD
Agomelatine—Irritability—Cisplatin—esophageal cancer	0.00273	0.0209	CcSEcCtD
Agomelatine—Naproxen—PTGS2—esophageal cancer	0.00256	0.0257	CrCbGaD
Agomelatine—Nasopharyngitis—Cisplatin—esophageal cancer	0.00256	0.0196	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00243	0.0186	CcSEcCtD
Agomelatine—Hepatic failure—Capecitabine—esophageal cancer	0.00235	0.018	CcSEcCtD
Agomelatine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00209	0.016	CcSEcCtD
Agomelatine—Migraine—Capecitabine—esophageal cancer	0.00208	0.0159	CcSEcCtD
Agomelatine—Indomethacin—PTGS2—esophageal cancer	0.00207	0.0208	CrCbGaD
Agomelatine—Face oedema—Capecitabine—esophageal cancer	0.00204	0.0156	CcSEcCtD
Agomelatine—Irritability—Capecitabine—esophageal cancer	0.00201	0.0154	CcSEcCtD
Agomelatine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00195	0.0149	CcSEcCtD
Agomelatine—Nasopharyngitis—Capecitabine—esophageal cancer	0.00189	0.0144	CcSEcCtD
Agomelatine—Eye disorder—Cisplatin—esophageal cancer	0.00185	0.0142	CcSEcCtD
Agomelatine—Tinnitus—Cisplatin—esophageal cancer	0.00185	0.0141	CcSEcCtD
Agomelatine—Influenza—Capecitabine—esophageal cancer	0.00182	0.0139	CcSEcCtD
Agomelatine—Indomethacin—ABCB1—esophageal cancer	0.00176	0.0177	CrCbGaD
Agomelatine—Hepatic failure—Methotrexate—esophageal cancer	0.00175	0.0134	CcSEcCtD
Agomelatine—Weight increased—Capecitabine—esophageal cancer	0.00166	0.0127	CcSEcCtD
Agomelatine—Weight decreased—Capecitabine—esophageal cancer	0.00165	0.0126	CcSEcCtD
Agomelatine—Infestation NOS—Capecitabine—esophageal cancer	0.00163	0.0124	CcSEcCtD
Agomelatine—Infestation—Capecitabine—esophageal cancer	0.00163	0.0124	CcSEcCtD
Agomelatine—Vision blurred—Cisplatin—esophageal cancer	0.00162	0.0124	CcSEcCtD
Agomelatine—Depression—Capecitabine—esophageal cancer	0.00162	0.0124	CcSEcCtD
Agomelatine—Tremor—Cisplatin—esophageal cancer	0.00161	0.0124	CcSEcCtD
Agomelatine—Jaundice—Capecitabine—esophageal cancer	0.00158	0.0121	CcSEcCtD
Agomelatine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00154	0.0118	CcSEcCtD
Agomelatine—Irritability—Methotrexate—esophageal cancer	0.0015	0.0115	CcSEcCtD
Agomelatine—Anxiety—Cisplatin—esophageal cancer	0.00146	0.0112	CcSEcCtD
Agomelatine—Hepatitis—Capecitabine—esophageal cancer	0.00146	0.0112	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00146	0.0111	CcSEcCtD
Agomelatine—Connective tissue disorder—Capecitabine—esophageal cancer	0.00143	0.011	CcSEcCtD
Agomelatine—Infection—Cisplatin—esophageal cancer	0.0014	0.0107	CcSEcCtD
Agomelatine—Nervous system disorder—Cisplatin—esophageal cancer	0.00138	0.0106	CcSEcCtD
Agomelatine—Skin disorder—Cisplatin—esophageal cancer	0.00137	0.0104	CcSEcCtD
Agomelatine—Eye disorder—Capecitabine—esophageal cancer	0.00136	0.0104	CcSEcCtD
Agomelatine—Tinnitus—Capecitabine—esophageal cancer	0.00136	0.0104	CcSEcCtD
Agomelatine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00136	0.0104	CcSEcCtD
Agomelatine—Mental disorder—Capecitabine—esophageal cancer	0.00128	0.00978	CcSEcCtD
Agomelatine—Paraesthesia—Cisplatin—esophageal cancer	0.00126	0.00966	CcSEcCtD
Agomelatine—Back pain—Capecitabine—esophageal cancer	0.00123	0.0094	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00121	0.00929	CcSEcCtD
Agomelatine—Infestation NOS—Methotrexate—esophageal cancer	0.00121	0.00926	CcSEcCtD
Agomelatine—Infestation—Methotrexate—esophageal cancer	0.00121	0.00926	CcSEcCtD
Agomelatine—Depression—Methotrexate—esophageal cancer	0.00121	0.00923	CcSEcCtD
Agomelatine—Vision blurred—Capecitabine—esophageal cancer	0.0012	0.00916	CcSEcCtD
Agomelatine—Tremor—Capecitabine—esophageal cancer	0.00119	0.0091	CcSEcCtD
Agomelatine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00114	0.00875	CcSEcCtD
Agomelatine—Vertigo—Capecitabine—esophageal cancer	0.00114	0.00873	CcSEcCtD
Agomelatine—Hepatitis—Methotrexate—esophageal cancer	0.00109	0.00831	CcSEcCtD
Agomelatine—Anxiety—Capecitabine—esophageal cancer	0.00108	0.00824	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00107	0.00822	CcSEcCtD
Agomelatine—Dry mouth—Capecitabine—esophageal cancer	0.00106	0.00809	CcSEcCtD
Agomelatine—Infection—Capecitabine—esophageal cancer	0.00103	0.00788	CcSEcCtD
Agomelatine—Nervous system disorder—Capecitabine—esophageal cancer	0.00102	0.00778	CcSEcCtD
Agomelatine—Eye disorder—Methotrexate—esophageal cancer	0.00102	0.00777	CcSEcCtD
Agomelatine—Tinnitus—Methotrexate—esophageal cancer	0.00101	0.00775	CcSEcCtD
Agomelatine—Asthenia—Cisplatin—esophageal cancer	0.00101	0.00772	CcSEcCtD
Agomelatine—Skin disorder—Capecitabine—esophageal cancer	0.00101	0.0077	CcSEcCtD
Agomelatine—Hyperhidrosis—Capecitabine—esophageal cancer	0.001	0.00767	CcSEcCtD
Agomelatine—Diarrhoea—Cisplatin—esophageal cancer	0.000962	0.00736	CcSEcCtD
Agomelatine—Mental disorder—Methotrexate—esophageal cancer	0.000952	0.00728	CcSEcCtD
Agomelatine—Insomnia—Capecitabine—esophageal cancer	0.000938	0.00717	CcSEcCtD
Agomelatine—Paraesthesia—Capecitabine—esophageal cancer	0.000931	0.00712	CcSEcCtD
Agomelatine—Back pain—Methotrexate—esophageal cancer	0.000915	0.007	CcSEcCtD
Agomelatine—Dyspepsia—Capecitabine—esophageal cancer	0.000913	0.00698	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000895	0.00685	CcSEcCtD
Agomelatine—Vomiting—Cisplatin—esophageal cancer	0.000894	0.00684	CcSEcCtD
Agomelatine—Fatigue—Capecitabine—esophageal cancer	0.000894	0.00684	CcSEcCtD
Agomelatine—Vision blurred—Methotrexate—esophageal cancer	0.000891	0.00682	CcSEcCtD
Agomelatine—Constipation—Capecitabine—esophageal cancer	0.000887	0.00678	CcSEcCtD
Agomelatine—Vertigo—Methotrexate—esophageal cancer	0.00085	0.0065	CcSEcCtD
Agomelatine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000848	0.00648	CcSEcCtD
Agomelatine—Nausea—Cisplatin—esophageal cancer	0.000836	0.00639	CcSEcCtD
Agomelatine—Urticaria—Capecitabine—esophageal cancer	0.000824	0.0063	CcSEcCtD
Agomelatine—Abdominal pain—Capecitabine—esophageal cancer	0.00082	0.00627	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.0008	0.00612	CcSEcCtD
Agomelatine—Infection—Methotrexate—esophageal cancer	0.000767	0.00586	CcSEcCtD
Agomelatine—Nervous system disorder—Methotrexate—esophageal cancer	0.000757	0.00579	CcSEcCtD
Agomelatine—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000754	0.00102	CbGpPWpGaD
Agomelatine—Skin disorder—Methotrexate—esophageal cancer	0.00075	0.00573	CcSEcCtD
Agomelatine—HTR2B—Signaling Pathways—KMT2D—esophageal cancer	0.000748	0.00102	CbGpPWpGaD
Agomelatine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000746	0.00571	CcSEcCtD
Agomelatine—Asthenia—Capecitabine—esophageal cancer	0.000744	0.00569	CcSEcCtD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000739	0.001	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000738	0.001	CbGpPWpGaD
Agomelatine—Pruritus—Capecitabine—esophageal cancer	0.000734	0.00561	CcSEcCtD
Agomelatine—HTR2B—GPCR downstream signaling—PDE4D—esophageal cancer	0.000733	0.000996	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AKAP13—esophageal cancer	0.000728	0.000989	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000719	0.000977	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TGFBR2—esophageal cancer	0.000716	0.000972	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TGFBR2—esophageal cancer	0.000716	0.000972	CbGpPWpGaD
Agomelatine—Diarrhoea—Capecitabine—esophageal cancer	0.000709	0.00543	CcSEcCtD
Agomelatine—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000709	0.000963	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000704	0.000956	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.000704	0.000956	CbGpPWpGaD
Agomelatine—Insomnia—Methotrexate—esophageal cancer	0.000698	0.00534	CcSEcCtD
Agomelatine—HTR2B—GPCR downstream signaling—GNG7—esophageal cancer	0.000697	0.000947	CbGpPWpGaD
Agomelatine—Paraesthesia—Methotrexate—esophageal cancer	0.000693	0.0053	CcSEcCtD
Agomelatine—Somnolence—Methotrexate—esophageal cancer	0.000686	0.00525	CcSEcCtD
Agomelatine—Dizziness—Capecitabine—esophageal cancer	0.000686	0.00524	CcSEcCtD
Agomelatine—Dyspepsia—Methotrexate—esophageal cancer	0.000679	0.0052	CcSEcCtD
Agomelatine—MTNR1A—Signaling Pathways—SMAD4—esophageal cancer	0.000677	0.00092	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SMAD4—esophageal cancer	0.000677	0.00092	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADCYAP1—esophageal cancer	0.000667	0.000906	CbGpPWpGaD
Agomelatine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000666	0.0051	CcSEcCtD
Agomelatine—HTR2B—Signaling by GPCR—PDE4D—esophageal cancer	0.000666	0.000904	CbGpPWpGaD
Agomelatine—Fatigue—Methotrexate—esophageal cancer	0.000666	0.00509	CcSEcCtD
Agomelatine—Vomiting—Capecitabine—esophageal cancer	0.000659	0.00504	CcSEcCtD
Agomelatine—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.000653	0.000888	CbGpPWpGaD
Agomelatine—Headache—Capecitabine—esophageal cancer	0.00065	0.00497	CcSEcCtD
Agomelatine—HTR2C—GPCR downstream signaling—AKAP13—esophageal cancer	0.000646	0.000878	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000644	0.000876	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—GNG7—esophageal cancer	0.000633	0.00086	CbGpPWpGaD
Agomelatine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000631	0.00483	CcSEcCtD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00063	0.000856	CbGpPWpGaD
Agomelatine—Nausea—Capecitabine—esophageal cancer	0.000616	0.00471	CcSEcCtD
Agomelatine—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.000614	0.000835	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCL2—esophageal cancer	0.000614	0.000834	CbGpPWpGaD
Agomelatine—Urticaria—Methotrexate—esophageal cancer	0.000613	0.00469	CcSEcCtD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000613	0.000833	CbGpPWpGaD
Agomelatine—Abdominal pain—Methotrexate—esophageal cancer	0.00061	0.00467	CcSEcCtD
Agomelatine—HTR2B—Signaling Pathways—WWOX—esophageal cancer	0.00061	0.000829	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000606	0.000823	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KMT2D—esophageal cancer	0.000604	0.00082	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.0006	0.000815	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.0006	0.000815	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PDE4D—esophageal cancer	0.000591	0.000803	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKAP13—esophageal cancer	0.000587	0.000798	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FKBP1A—esophageal cancer	0.00058	0.000788	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ANXA1—esophageal cancer	0.000571	0.000776	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—WIF1—esophageal cancer	0.000567	0.000771	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—GNG7—esophageal cancer	0.000562	0.000764	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL2—esophageal cancer	0.000558	0.000758	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—SST—esophageal cancer	0.000555	0.000755	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HIF1A—esophageal cancer	0.000554	0.000753	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HIF1A—esophageal cancer	0.000554	0.000753	CbGpPWpGaD
Agomelatine—Asthenia—Methotrexate—esophageal cancer	0.000554	0.00424	CcSEcCtD
Agomelatine—Pruritus—Methotrexate—esophageal cancer	0.000546	0.00418	CcSEcCtD
Agomelatine—HTR2B—GPCR downstream signaling—GHRL—esophageal cancer	0.000541	0.000735	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADCYAP1—esophageal cancer	0.000538	0.000731	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PDE4D—esophageal cancer	0.000537	0.000729	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—KDR—esophageal cancer	0.00053	0.00072	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—KDR—esophageal cancer	0.00053	0.00072	CbGpPWpGaD
Agomelatine—Diarrhoea—Methotrexate—esophageal cancer	0.000528	0.00404	CcSEcCtD
Agomelatine—HTR2B—Signaling Pathways—CSNK1A1—esophageal cancer	0.000523	0.000711	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ANXA1—esophageal cancer	0.000519	0.000704	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—GNG7—esophageal cancer	0.000511	0.000694	CbGpPWpGaD
Agomelatine—Dizziness—Methotrexate—esophageal cancer	0.00051	0.0039	CcSEcCtD
Agomelatine—HTR2B—Signaling by GPCR—SST—esophageal cancer	0.000504	0.000685	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NOTCH1—esophageal cancer	0.000499	0.000678	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NOTCH1—esophageal cancer	0.000499	0.000678	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000498	0.000677	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000496	0.000674	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL2—esophageal cancer	0.000496	0.000673	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—WWOX—esophageal cancer	0.000492	0.000669	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—GHRL—esophageal cancer	0.000492	0.000668	CbGpPWpGaD
Agomelatine—Vomiting—Methotrexate—esophageal cancer	0.000491	0.00375	CcSEcCtD
Agomelatine—HTR2B—Signaling Pathways—PFN1—esophageal cancer	0.00049	0.000665	CbGpPWpGaD
Agomelatine—Headache—Methotrexate—esophageal cancer	0.000484	0.0037	CcSEcCtD
Agomelatine—HTR2B—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000482	0.000654	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FKBP1A—esophageal cancer	0.000468	0.000636	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ANXA1—esophageal cancer	0.000461	0.000626	CbGpPWpGaD
Agomelatine—Nausea—Methotrexate—esophageal cancer	0.000459	0.00351	CcSEcCtD
Agomelatine—HTR2C—Signaling Pathways—WIF1—esophageal cancer	0.000458	0.000622	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CREBBP—esophageal cancer	0.000453	0.000615	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CREBBP—esophageal cancer	0.000453	0.000615	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL2—esophageal cancer	0.00045	0.000611	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—SST—esophageal cancer	0.000448	0.000609	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—EGFR—esophageal cancer	0.000445	0.000604	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—EGFR—esophageal cancer	0.000445	0.000604	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ELMO1—esophageal cancer	0.00044	0.000598	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—GHRL—esophageal cancer	0.000437	0.000593	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000435	0.000591	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000431	0.000585	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKAP13—esophageal cancer	0.00043	0.000584	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000426	0.000578	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000425	0.000578	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000425	0.000578	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CSNK1A1—esophageal cancer	0.000422	0.000574	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ANXA1—esophageal cancer	0.000418	0.000568	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—SST—esophageal cancer	0.000407	0.000553	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NOS3—esophageal cancer	0.000405	0.000551	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NOS3—esophageal cancer	0.000405	0.000551	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.0004	0.000544	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000397	0.000539	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—GHRL—esophageal cancer	0.000397	0.000539	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PFN1—esophageal cancer	0.000395	0.000537	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PDE4D—esophageal cancer	0.000393	0.000534	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000389	0.000528	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000386	0.000525	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000386	0.000525	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—PIK3CA—esophageal cancer	0.000386	0.000525	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—PIK3CA—esophageal cancer	0.000386	0.000525	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ERBB2—esophageal cancer	0.000379	0.000515	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ERBB2—esophageal cancer	0.000379	0.000515	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GNG7—esophageal cancer	0.000374	0.000508	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000371	0.000505	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ELMO1—esophageal cancer	0.000355	0.000482	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—XIAP—esophageal cancer	0.00035	0.000476	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000348	0.000472	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKAP13—esophageal cancer	0.000347	0.000471	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000345	0.000469	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCND1—esophageal cancer	0.000335	0.000455	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCND1—esophageal cancer	0.000335	0.000455	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CTNNA1—esophageal cancer	0.000331	0.00045	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.00033	0.000449	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.00033	0.000449	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL2—esophageal cancer	0.000329	0.000448	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000328	0.000446	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CA1—esophageal cancer	0.000328	0.000446	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CDKN1A—esophageal cancer	0.000324	0.00044	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CDKN1A—esophageal cancer	0.000324	0.00044	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00032	0.000435	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PDE4D—esophageal cancer	0.000317	0.000431	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EP300—esophageal cancer	0.000308	0.000419	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EP300—esophageal cancer	0.000308	0.000419	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PSME1—esophageal cancer	0.000308	0.000418	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PSME2—esophageal cancer	0.000308	0.000418	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ANXA1—esophageal cancer	0.000306	0.000416	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GNG7—esophageal cancer	0.000302	0.00041	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CA2—esophageal cancer	0.0003	0.000408	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SST—esophageal cancer	0.000298	0.000405	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000295	0.000401	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000294	0.000399	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GHRL—esophageal cancer	0.00029	0.000394	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOTCH3—esophageal cancer	0.00029	0.000394	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FBXW7—esophageal cancer	0.000286	0.000388	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—XIAP—esophageal cancer	0.000283	0.000384	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CA1—esophageal cancer	0.000281	0.000381	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000281	0.000381	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.000279	0.000379	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADH7—esophageal cancer	0.000279	0.000379	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000276	0.000375	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MYC—esophageal cancer	0.000269	0.000365	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MYC—esophageal cancer	0.000269	0.000365	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CTNNA1—esophageal cancer	0.000267	0.000363	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL2—esophageal cancer	0.000266	0.000361	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EGFR—esophageal cancer	0.000263	0.000357	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EGFR—esophageal cancer	0.000263	0.000357	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOTCH2—esophageal cancer	0.00026	0.000354	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CA2—esophageal cancer	0.000257	0.000349	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000251	0.000341	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PSME2—esophageal cancer	0.000248	0.000337	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PSME1—esophageal cancer	0.000248	0.000337	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ANXA1—esophageal cancer	0.000247	0.000336	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.000245	0.000333	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SST—esophageal cancer	0.00024	0.000327	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PLCE1—esophageal cancer	0.000239	0.000324	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADH7—esophageal cancer	0.000239	0.000324	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000236	0.000321	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GHRL—esophageal cancer	0.000234	0.000318	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOTCH3—esophageal cancer	0.000234	0.000318	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TYMP—esophageal cancer	0.000234	0.000318	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TGFBR2—esophageal cancer	0.000231	0.000314	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FBXW7—esophageal cancer	0.00023	0.000313	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PIK3CA—esophageal cancer	0.000228	0.00031	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PIK3CA—esophageal cancer	0.000228	0.00031	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	0.000228	0.000309	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALOX15—esophageal cancer	0.000222	0.000301	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TP53—esophageal cancer	0.000221	0.0003	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TP53—esophageal cancer	0.000221	0.0003	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SMAD4—esophageal cancer	0.000219	0.000297	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTO1—esophageal cancer	0.000212	0.000288	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TPI1—esophageal cancer	0.000212	0.000288	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOTCH2—esophageal cancer	0.00021	0.000285	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADH1B—esophageal cancer	0.000209	0.000284	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALDOB—esophageal cancer	0.000203	0.000276	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TYMP—esophageal cancer	0.0002	0.000272	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GAPDH—esophageal cancer	0.000195	0.000265	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	0.000195	0.000264	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CRABP1—esophageal cancer	0.000194	0.000263	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALOX15—esophageal cancer	0.00019	0.000258	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TGFBR2—esophageal cancer	0.000186	0.000253	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GNG7—esophageal cancer	0.000184	0.00025	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTO1—esophageal cancer	0.000181	0.000246	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TPI1—esophageal cancer	0.000181	0.000246	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HIF1A—esophageal cancer	0.000179	0.000243	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SMAD4—esophageal cancer	0.000176	0.00024	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALDOB—esophageal cancer	0.000173	0.000236	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALDH2—esophageal cancer	0.000173	0.000234	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KDR—esophageal cancer	0.000171	0.000233	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GAPDH—esophageal cancer	0.000167	0.000227	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CRABP1—esophageal cancer	0.000165	0.000225	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTT1—esophageal cancer	0.000164	0.000223	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	0.000162	0.00022	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000162	0.00022	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOTCH1—esophageal cancer	0.000161	0.000219	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GNG7—esophageal cancer	0.000157	0.000214	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ENO1—esophageal cancer	0.000154	0.000209	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS1—esophageal cancer	0.000154	0.000209	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PSME2—esophageal cancer	0.000152	0.000206	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PSME1—esophageal cancer	0.000152	0.000206	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALDH2—esophageal cancer	0.000147	0.0002	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CREBBP—esophageal cancer	0.000146	0.000199	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HIF1A—esophageal cancer	0.000144	0.000196	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EGFR—esophageal cancer	0.000144	0.000195	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTT1—esophageal cancer	0.00014	0.000191	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	0.000139	0.000188	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000138	0.000188	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KDR—esophageal cancer	0.000138	0.000188	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000137	0.000186	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000132	0.00018	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS1—esophageal cancer	0.000131	0.000179	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ENO1—esophageal cancer	0.000131	0.000179	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOS3—esophageal cancer	0.000131	0.000178	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	0.000131	0.000178	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOTCH1—esophageal cancer	0.00013	0.000177	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PSME2—esophageal cancer	0.00013	0.000176	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PSME1—esophageal cancer	0.00013	0.000176	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3CA—esophageal cancer	0.000125	0.000169	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	0.000123	0.000167	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ERBB2—esophageal cancer	0.000122	0.000166	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CREBBP—esophageal cancer	0.000118	0.00016	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EGFR—esophageal cancer	0.000116	0.000157	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000113	0.000154	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMOX1—esophageal cancer	0.000112	0.000152	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	0.000112	0.000152	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000111	0.00015	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.00011	0.00015	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCND1—esophageal cancer	0.000108	0.000147	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCB1—esophageal cancer	0.000108	0.000146	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOS3—esophageal cancer	0.000106	0.000143	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	0.000105	0.000143	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CDKN1A—esophageal cancer	0.000105	0.000142	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CA—esophageal cancer	0.000101	0.000137	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EP300—esophageal cancer	9.95e-05	0.000135	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ERBB2—esophageal cancer	9.88e-05	0.000134	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMOX1—esophageal cancer	9.59e-05	0.00013	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.41e-05	0.000128	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCB1—esophageal cancer	9.2e-05	0.000125	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCND1—esophageal cancer	8.73e-05	0.000119	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MYC—esophageal cancer	8.67e-05	0.000118	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EGFR—esophageal cancer	8.48e-05	0.000115	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CDKN1A—esophageal cancer	8.44e-05	0.000115	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.14e-05	0.000111	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EP300—esophageal cancer	8.03e-05	0.000109	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CA—esophageal cancer	7.36e-05	0.0001	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CREBBP—esophageal cancer	7.2e-05	9.78e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TP53—esophageal cancer	7.12e-05	9.68e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MYC—esophageal cancer	7e-05	9.51e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.96e-05	9.45e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EGFR—esophageal cancer	6.85e-05	9.3e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NOS3—esophageal cancer	6.44e-05	8.75e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CREBBP—esophageal cancer	6.15e-05	8.36e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CA—esophageal cancer	5.94e-05	8.07e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS2—esophageal cancer	5.89e-05	8.01e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TP53—esophageal cancer	5.75e-05	7.81e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NOS3—esophageal cancer	5.51e-05	7.48e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS2—esophageal cancer	5.04e-05	6.84e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—EP300—esophageal cancer	4.9e-05	6.66e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—EP300—esophageal cancer	4.19e-05	5.69e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.63e-05	4.93e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.1e-05	4.21e-05	CbGpPWpGaD
